Form 4 for BKYI BIO KEY INTERNATIONAL INC
Accepted 2023-08-31 00:00:00 ET · period of report 2023-08-29 · accession 0001437749-23-024970 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-08-31 | 2023-08-29 | BKYI | LACOUS MIRA K | CTO | A - Grant | $0.00 | +10.0K | 31.6K | +46% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-08-29 | A | A | 10,000 | $0.00 | 31,625 | D | — | — | (F1) Restricted Stock granted to the Reporting person on August 29, 2023 under the Issuer's Amended and Restated 2015 Equity Incentive Plan, which vest in three equal annual installments on each of the next three anniversaries of the grant date, subject to the Reporting Person's continued employment with or service to the Issuer through the applicable vesting date. |